Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 4Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 2Endocrine 1

Conditions

Breast Neoplasms 2Pituitary Neoplasms 1Abdominal Cancer 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Supine Position × Clear all
NCT06293391 2026-04-30

The Effect of Patient Position Changes on Advanced Cardiac Indices in Cancer Surgery

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Completed
80 enrolled

Abdominal Cancer

NCT04584866 2025-04-29

PosESS

University Hospital, Basel, Switzerland

Phase NA Completed
54 enrolled
Endocrine

Pituitary Neoplasms

NCT00887523 2022-12-20

Trial Comparing Prone and Supine Intensity-modulated Radiotherapy (IMRT) After Breast-conserving Surgery in Patients With Large Breast Volume at High Risk for Skin Toxicity and Fibrosis

University Hospital, Ghent

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms

NCT00887692 2010-10-19

Comparison of Set-up Reproducibility Between Prone and Supine Intensity Modulated Radiotherapy (IMRT) for the Adjuvant Treatment of Breast Carcinoma After Lumpectomy

University Hospital, Ghent

Phase NA Completed
10 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡